These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus. Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871 [TBL] [Abstract][Full Text] [Related]
3. Interaction of L-dopa and GHRH on GH secretion in normal men. Alba-Roth J; von Creytz C; Mehltretter G; Schopohl J; Müller OA; von Werder K J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218 [TBL] [Abstract][Full Text] [Related]
4. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion. Kelijman M; Frohman LA J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420 [TBL] [Abstract][Full Text] [Related]
5. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro. Szabo M; Stachura ME; Paleologos N; Bybee DE; Frohman LA Endocrinology; 1984 Apr; 114(4):1344-51. PubMed ID: 6423373 [TBL] [Abstract][Full Text] [Related]
6. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion. Mota A; Bento A; Peñalva A; Pombo M; Dieguez C J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648 [TBL] [Abstract][Full Text] [Related]
7. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313 [TBL] [Abstract][Full Text] [Related]
8. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [TBL] [Abstract][Full Text] [Related]
9. Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man. Giusti M; Lomeo A; Mazzocchi G; Torre R; Monachesi M; Sessarego P; Attanasio R; Giordano G J Endocrinol Invest; 1986 Dec; 9(6):497-501. PubMed ID: 3106459 [TBL] [Abstract][Full Text] [Related]
10. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494 [TBL] [Abstract][Full Text] [Related]
11. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy. Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864 [TBL] [Abstract][Full Text] [Related]
12. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573 [TBL] [Abstract][Full Text] [Related]
13. Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. Bellone J; Bartolotta E; Cardinale G; Arvat E; Cherubini V; Aimaretti G; Maccario M; Mucci M; Camanni F; Ghigo E J Endocrinol Invest; 1993; 16(7):521-5. PubMed ID: 8227981 [TBL] [Abstract][Full Text] [Related]
14. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion. Kelijman M; Frohman LA J Clin Endocrinol Metab; 1988 Apr; 66(4):872-5. PubMed ID: 3126217 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304 [TBL] [Abstract][Full Text] [Related]
16. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467 [TBL] [Abstract][Full Text] [Related]
17. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release. Michalkiewicz M; Suzuki M; Kato M Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Kineman RD; Kamegai J; Frohman LA Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214 [TBL] [Abstract][Full Text] [Related]
19. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose. Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634 [TBL] [Abstract][Full Text] [Related]
20. Lack of effect of hexarelin on TRH-induced TSH response in normal adult man. Arosio M; Casati G; Biella O; Porretti S; Imbimbo BP; Faglia G J Endocrinol Invest; 1998 Apr; 21(4):239-44. PubMed ID: 9624598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]